The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Editorial

STEMI outcomes in the era of COVID-19: reaffirmation of an unfortunate reality

EuroIntervention 2021;16:1379-1380. DOI: 10.4244/EIJV16I17A250

1. New York University Grossman School of Medicine, New York, NY, USA


While it is generally accepted that patients with COVID-19 who have cardiac comorbidities suffer from a substantially increased risk of adverse outcomes, establishing a cohesive understanding of this relationship has proven elusive. Moreover, as healthcare systems continue to grapple with the relentless and often unforeseen challenges that accompany this global pandemic, progress in unravelling the virus’ pathobiology and seemingly pleiotropic effects has been additionally complicated by the disrupted delivery of even routine care. A blunted recognition of comorbid cardiovascular conditions coupled with uncertainty regarding how concomitant infection with a novel, highly contagious pathogen should influence treatment has likely ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
To be better among the best: a difficult task

Latest news